Exablate Neuro cleared for SIGNA Premier

GE Healthcare and Insightec^®, a global medical innovator of incisionless surgery, announced US and EU regulatory approval for Exablate Neuro^TM compatible with the SIGNA^TM Premier MR system. Exablate Neuro^TM is a focused ultrasound platform for treating the brain with no surgical incisions. MR imaging provides a comprehensive anatomical survey of the treatment area, patient-specific planning and real-time thermal monitoring throughout the treatment.

Exablate Neuro^TM has FDA approval for the treatment of medication-refractory essential tremor and tremor-dominant Parkinson’s disease and CE marked for the treatment of essential tremor, tremor dominant Parkinson’s Disease-Unilateral and neuropathic pain. “We’re excited to continue expanding MR-guided focused ultrasound offerings with Insightec^®,” said Baldev Ahluwalia, General Manager, MR Beyond Segment at GE Healthcare.